Skip to content
← Back to this collection

PUBLICATIONS · 11481351

Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2001 Aug 1
First author
Saylors RL 3rd

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Saylors RL 3rd
      type
      Author
    2. name
      Stine KC
      type
      Author
    3. name
      Sullivan J
      type
      Author
    4. name
      Kepner JL
      type
      Author
    5. name
      Wall DA
      type
      Author
    6. name
      Bernstein ML
      type
      Author
    7. name
      Harris MB
      type
      Author
    8. name
      Hayashi R
      type
      Author
    9. name
      Vietti TJ
      type
      Author
    10. name
      Pediatric Oncology Group
      type
      CollectiveName
    Complete bibliographic record and source provenance
    authors
    1. name
      Saylors RL 3rd
      type
      Author
    2. name
      Stine KC
      type
      Author
    3. name
      Sullivan J
      type
      Author
    4. name
      Kepner JL
      type
      Author
    5. name
      Wall DA
      type
      Author
    6. name
      Bernstein ML
      type
      Author
    7. name
      Harris MB
      type
      Author
    8. name
      Hayashi R
      type
      Author
    9. name
      Vietti TJ
      type
      Author
    10. name
      Pediatric Oncology Group
      type
      CollectiveName
    bibliography ids
    1. nci-bib-eabac216e4c7f989e73c4487
    book metadata
    content sha256
    03f7297f523002bf6edfe96c8a7b72450c74a4db93083ff882573c58c96eae11
    document type
    citation
    dois
    1. 10.1200/JCO.2001.19.15.3463
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:11481351
    immutable id
    pubmed:11481351@03f7297f523002bf6edfe96c8a7b72450c74a4db93083ff882573c58c96eae11
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    15
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3463-9
    volume
    19
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      11481351
      provenance
      batch id
      bc1299bcdb6a81bdf655
      provider
      NCBI PubMed ESummary
      record sha256
      b49ea11bfba16caa18d2b48f3b75c504f4843035860b18ab5c47fd79cd81f5ef
      response sha256
      c4d63e9a162706394efcc7d20cd416503379c383137f167684654db2709afc4f
      retrieved at
      2026-09-09T23:45:42.126507+00:00
      publication date
      display
      2001 Aug 1
      precision
      day
      year
      2001
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Multicenter Study
      5. Research Support, U.S. Gov't, P.H.S.
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/11481351/
      title
      Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study.

      Preserved source evidence · Not medical advice